NuOncology Labs Overview
- Status
- Public
- Employees
- 1

- Stock Symbol
- NLABD

- Share Price
- $297.00
- (As of Tuesday Closing)
NuOncology Labs General Information
Description
Taihe Group Inc formerly, NuOncology Labs Inc is a United States based company and provides predictive chemosensitivity and immunotherapy predictive tests on biopsy tissues and other oncological laboratory testing services and products. NLAB's operations include development, identification, testing and licensing of cancer treatment compounds.
Contact Information
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
PINX
Primary Office
- 4870 Haygood Road
- Suite 107
- Virginia Beach, VA 23455
- United States
+1 (757) 000-0000
NuOncology Labs Stock Performance
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$297.00 | $300.00 | $968K | 3.26K | 6.09 | -$9.00 |
NuOncology Labs Financials Summary
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
---|---|---|---|
EV | 2,973 | ||
Revenue | 0 | 0 | 0 |
EBITDA | (42) | (29) | 0 |
Net Income | (42) | (29) | 0 |
Total Assets | 0 | 0 | 0 |
Total Debt | 12 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
NuOncology Labs Signals
Growth Rate

0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile

-35.5%.
530%
Size Multiple

219x
Median
Size Multiple
219x, 100th %ile

0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial